The DOI matches its Crossref record; 240 of the 240 references it cites were found in a registry or an index.
Gene delivery by lentivirus vectors
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341 · cited 5×
“Despite these improvements in transduction efficiency, a large body of evidence, including initial reports using HIV-1 vectors [12, 28, 29, 33, 34, 48], indicates that the DNA flap is not absolutely required for vector transduction, or even for wild-type HIV-1 replication [105, 106].”
BackgroundMethodInfluentialTranscriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
Cavazzana-Calvo, M., Hacein-Bey, S., Basile, G. D. S., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.-L., et al. (2000) · Science · doi:10.1126/science.288.5466.669 · Cited by 2,167
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
Chun, T.-W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., et al. (1997) · Nature · doi:10.1038/387183a0 · Cited by 2,050 · cited 1×
“During the natural course of HIV-1 infection, at least four forms of non-integrated DNA have been detected in tissue reservoirs and tissue culture comprising the majority (>90%) of HIV-1 DNA forms present in infected cells: linear, 2-LTR, 1-LTR, and autointegrant (mutant) episomal forms [61–64].”
BackgroundGermline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors
Lois, C., Hong, E. J., Pease, S., Brown, E. J., & Baltimore, D. (2002) · Science · doi:10.1126/science.1067081 · Cited by 1,999
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.-L., Fraser, C. C., Cavazzana-Calvo, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejm200301163480314 · Cited by 1,867 · cited 3×
“Successful correction of three hematopoietic disorders in humans was achieved with simple retroviral based vectors (ADA-SCID, SCID-X1, and X-linked CGD [3–7]); nonetheless, excitement was tempered by the finding that insertional mutagenesis had resulted in leukemogenesis in three patients from a SCID-X1 clinical trial…”
BackgroundSelf-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery
Zufferey, R., Dull, T., Mandel, R. J., Bukovsky, A., Quiroz, D., Naldini, L., & Trono, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9873-9880.1998 · Cited by 1,815
A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T. M., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,798
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells
Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J., & Conklin, D. S. (2002) · Genes & Development · doi:10.1101/gad.981002 · Cited by 1,552
Rubinson, D. A., Dillon, C. P., Kwiatkowski, A. V., Sievers, C., Yang, L., Kopinja, J., Rooney, D. L., Zhang, M., Ihrig, M. M., McManus, M. T., et al. (2003) · Nature Genetics · doi:10.1038/ng1117 · Cited by 1,501
Naldini, L., Blömer, U., Gage, F. H., Trono, D., & Verma, I. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11382 · Cited by 1,499
Kordower, J. H., Emborg, M. E., Bloch, J., Ma, S. Y., Chu, Y., Leventhal, L., McBride, J., Chen, E.-Y., Palfi, S., Roitberg, B. Z., et al. (2000) · Science · doi:10.1126/science.290.5492.767 · Cited by 1,251
Development of a self-inactivating lentivirus vector
Miyoshi, H., Blömer, U., Takahashi, M., Gage, F. H., & Verma, I. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8150-8157.1998 · Cited by 1,196 · cited 2×
“A critical improvement in vector safety was the deletion of the enhancer/promoter sequences in the U3 region of the 3¢ LTR, which defines the vectors as self-inactivating (SIN) [78–80] (Fig.”
BackgroundA large-scale RNAi screen in human cells identifies new components of the p53 pathway
Berns, K., Hijmans, E. M., Mullenders, J., Brummelkamp, T. R., Velds, A., Heimerikx, M., Kerkhoven, R. M., Madiredjo, M., Nijkamp, W., Weigelt, B., et al. (2004) · Nature · doi:10.1038/nature02371 · Cited by 1,065
Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy
Hacein-Bey-Abina, S., Le Deist, F., Carlier, F., Bouneaud, C., Hue, C., De Villartay, J.-P., Thrasher, A. J., Wulffraat, N., Sorensen, R., Dupuis-Girod, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012616 · Cited by 1,058
Ott, M. G., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U., Glimm, H., Kühlcke, K., Schilz, A., Kunkel, H., et al. (2006) · Nature Medicine · doi:10.1038/nm1393 · Cited by 1,051
Zufferey, R., Donello, J. E., Trono, D., & Hope, T. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2886-2892.1999 · Cited by 1,014
Absence of Intact nef Sequences in a Long-Term Survivor with Nonprogressive HIV-1 Infection
Kirchhoff, F., Greenough, T. C., Brettler, D. B., Sullivan, J. L., & Desrosiers, R. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501263320405 · Cited by 1,003
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
Aiuti, A., Slavin, S., Aker, M., Ficara, F., Deola, S., Mortellaro, A., Morecki, S., Andolfi, G., Tabucchi, A., Carlucci, F., et al. (2002) · Science · doi:10.1126/science.1070104 · Cited by 975
Urlinger, S., Baron, U., Thellmann, M., Hasan, M. T., Bujard, H., & Hillen, W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130192197 · Cited by 928
Follenzi, A., Ailles, L. E., Bakovic, S., Geuna, M., & Naldini, L. (2000) · Nature Genetics · doi:10.1038/76095 · Cited by 927
Stable suppression of tumorigenicity by virus-mediated RNA interference
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00122-8 · Cited by 886
siRNA-mediated gene silencing in vitro and in vivo
Xia, H., Mao, Q., Paulson, H. L., & Davidson, B. L. (2002) · Nature Biotechnology · doi:10.1038/nbt739 · Cited by 873
HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap
Zennou, V., Petit, C., Guetard, D., Nerhbass, U., Montagnier, L., & Charneau, P. (2000) · Cell · doi:10.1016/s0092-8674(00)80828-4 · Cited by 833
Effective expression of small interfering RNA in human cells
Paul, C. P., Good, P. D., Winer, I., & Engelke, D. R. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-505 · Cited by 820
microPrimer: the biogenesis and function of microRNA
Du, T., & Zamore, P. D. (2005) · Development · doi:10.1242/dev.02070 · Cited by 813
Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector
Blömer, U., Naldini, L., Kafri, T., Trono, D., Verma, I. M., & Gage, F. H. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6641-6649.1997 · Cited by 725
Self-citationWiznerowicz, M., & Trono, D. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8957-8951.2003 · Cited by 701
Qin, X.-F., An, D. S., Chen, I. S. Y., & Baltimore, D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232688199 · Cited by 701
A resource for large-scale RNA-interference-based screens in mammals
Paddison, P. J., Silva, J. M., Conklin, D. S., Schlabach, M., Li, M., Aruleba, S., Balija, V., O'Shaughnessy, A., Gnoj, L., Scobie, K., et al. (2004) · Nature · doi:10.1038/nature02370 · Cited by 695
Gaspar, H. B., Parsley, K. L., Howe, S., King, D., Gilmour, K. C., Sinclair, J., Brouns, G., Schmidt, M., Von Kalle, C., Barington, T., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17590-9 · Cited by 689
Cre-lox-regulated conditional RNA interference from transgenes
Ventura, A., Meissner, A., Dillon, C. P., McManus, M., Sharp, P. A., Van Parijs, L., Jaenisch, R., & Jacks, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403954101 · Cited by 625
Miyoshi, H., Smith, K. A., Mosier, D. E., Verma, I. M., & Torbett, B. E. (1999) · Science · doi:10.1126/science.283.5402.682 · Cited by 624
Second-generation shRNA libraries covering the mouse and human genomes
Silva, J. M., Li, M. Z., Chang, K., Ge, W., Golding, M. C., Rickles, R. J., Siolas, D., Hu, G., Paddison, P. J., Schlabach, M. R., et al. (2005) · Nature Genetics · doi:10.1038/ng1650 · Cited by 622
Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
Kafri, T., Blömer, U., Peterson, D. A., Gage, F. H., & Verma, I. M. (1997) · Nature Genetics · doi:10.1038/ng1197-314 · Cited by 605
Self-citationCorrection of sickle cell disease in transgenic mouse models by gene therapy
Pawliuk, R., Westerman, K. A., Fabry, M. E., Payen, E., Tighe, R., Bouhassira, E. E., Acharya, S. A., Ellis, J., London, I. M., Eaves, C. J., et al. (2001) · Science · doi:10.1126/science.1065806 · Cited by 579 · cited 1×
“demonstrating efficient transduction of human HSCs with lentiviral vectors [195], several researchers have reported successful correction of genetic disorders in preclinical animal models, including immunodeficiencies and various hemoglobin disorders [54, 196–203].”
May, C., Rivella, S., Callegari, J., Heller, G., Gaensler, K. M. L., Luzzatto, L., & Sadelain, M. (2000) · Nature · doi:10.1038/35017565 · Cited by 567
Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells.
Yu, S. F., von Rüden, T., Kantoff, P. W., Garber, C., Seiberg, M., Rüther, U., Anderson, W. F., Wagner, E. F., & Gilboa, E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3194 · Cited by 541
Tiscornia, G., Singer, O., Ikawa, M., & Verma, I. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437912100 · Cited by 540
Altering the Tropism of Lentiviral Vectors through Pseudotyping
Cronin, J., Zhang, X.-Y., & Reiser, J. (2005) · Current Gene Therapy · doi:10.2174/1566523054546224 · Cited by 536
Stegmeier, F., Hu, G., Rickles, R. J., Hannon, G. J., & Elledge, S. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506306102 · Cited by 532
Human immunodeficiency virus infection of cells arrested in the cell cycle.
Lewis, P., Hensel, M., & Emerman, M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05376.x · Cited by 531
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors
Dickins, R. A., Hemann, M. T., Zilfou, J. T., Simpson, D. R., Ibarra, I., Hannon, G. J., & Lowe, S. W. (2005) · Nature Genetics · doi:10.1038/ng1651 · Cited by 524
Pfeifer, A., Ikawa, M., Dayn, Y., & Verma, I. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251682798 · Cited by 522
Ralph, G. S., Radcliffe, P. A., Day, D. M., Carthy, J. M., Leroux, M. A., Lee, D. C. P., Wong, L.-F., Bilsland, L. G., Greensmith, L., Kingsman, S. M., et al. (2005) · Nature Medicine · doi:10.1038/nm1205 · Cited by 506
Gene transfer in humans using a conditionally replicating lentiviral vector
Levine, B. L., Humeau, L. M., Boyer, J., MacGregor, R.-R., Rebello, T., Lu, X., Binder, G. K., Slepushkin, V., Lemiale, F., Mascola, J. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608138103 · Cited by 501
Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector
Miyoshi, H., Takahashi, M., Gage, F. H., & Verma, I. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10319 · Cited by 494
Gallay, P., Hope, T., Chin, D., & Trono, D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9825 · Cited by 485
Raoul, C., Abbas-Terki, T., Bensadoun, J.-C., Guillot, S., Haase, G., Szulc, J., Henderson, C. E., & Aebischer, P. (2005) · Nature Medicine · doi:10.1038/nm1207 · Cited by 464
Effective gene therapy with nonintegrating lentiviral vectors
Yáñez-Muñoz, R. J., Balaggan, K. S., MacNeil, A., Howe, S. J., Schmidt, M., Smith, A. J., Buch, P., MacLaren, R. E., Anderson, P. N., Barker, S. E., et al. (2006) · Nature Medicine · doi:10.1038/nm1365 · Cited by 460
Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication
Engelman, A., Englund, G., Orenstein, J. M., Martin, M. A., & Craigie, R. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.2729-2736.1995 · Cited by 445
Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model
Singer, O., Marr, R. A., Rockenstein, E., Crews, L., Coufal, N. G., Gage, F. H., Verma, I. M., & Masliah, E. (2005) · Nature Neuroscience · doi:10.1038/nn1531 · Cited by 428
Poeschla, E. M., Wong-Staal, F., & Looney, D. J. (1998) · Nature Medicine · doi:10.1038/nm0398-354 · Cited by 416
Sayan, B. S. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401459 · Cited by 388
HIV-1 Reverse Transcription A Termination Step at the Center of the Genome
Charneau, P., Mirambeau, G., Roux, P., Paulous, S., Buc, H., & Clavel, F. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1542 · Cited by 388
Efficient production of germline transgenic chickens using lentiviral vectors
McGrew, M. J., Sherman, A., Ellard, F. M., Lillico, S. G., Gilhooley, H. J., Kingsman, A. J., Mitrophanous, K. A., & Sang, H. (2004) · EMBO reports · doi:10.1038/sj.embor.7400171 · Cited by 379
Silencing and Variegation of Gammaretrovirus and Lentivirus Vectors
Ellis, J. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1241 · Cited by 379
High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients
Pang, S., Koyanagi, Y., Miles, S., Wiley, C., Vinters, H. V., & Chen, I. S. Y. (1990) · Nature · doi:10.1038/343085a0 · Cited by 377
Gallay, P., Swingler, S., Song, J., Bushman, F., & Trono, D. (1995) · Cell · doi:10.1016/0092-8674(95)90097-7 · Cited by 359
Genome-scale loss-of-function screening with a lentiviral RNAi library
Root, D. E., Hacohen, N., Hahn, W. C., Lander, E. S., & Sabatini, D. M. (2006) · Nature Methods · doi:10.1038/nmeth924 · Cited by 357
Aiken, C. (1997) · Journal of Virology · doi:10.1128/jvi.71.8.5871-5877.1997 · Cited by 356
A versatile tool for conditional gene expression and knockdown
Szulc, J., Wiznerowicz, M., Sauvain, M.-O., Trono, D., & Aebischer, P. (2006) · Nature Methods · doi:10.1038/nmeth846 · Cited by 351
326. A Versatile Tool for Conditional Gene Expression and Knockdown
Szulc, J., Wiznerowicz, M., Beermann, F., Trono, D., & Aebischer, P. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.08.383 · Cited by 350
Björklund, A., Kirik, D., Rosenblad, C., Georgievska, B., Lundberg, C., & Mandel, R. J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02915-2 · Cited by 346
Shin, K.-J., Wall, E. A., Zavzavadjian, J. R., Santat, L. A., Liu, J., Hwang, J.-I., Rebres, R., Roach, T., Seaman, W., Simon, M. I., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606179103 · Cited by 332
Efficient lentiviral transduction of liver requires cell cycling in vivo
Park, F., Ohashi, K., Chiu, W., Naldini, L., & Kay, M. A. (2000) · Nature Genetics · doi:10.1038/71673 · Cited by 323
Akkina, R. K., Walton, R. M., Chen, M. L., Li, Q. X., Planelles, V, & Chen, I. S. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2581-2585.1996 · Cited by 321
Kobinger, G. P., Weiner, D. J., Yu, Q.-C., & Wilson, J. M. (2001) · Nature Biotechnology · doi:10.1038/85664 · Cited by 307
Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods
Sastry, L., Johnson, T., Hobson, M. J., Smucker, B., & Cornetta, K. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301731 · Cited by 295
Silencing of HIV-1 with RNA Interference: a Multiple shRNA Approach
ter Brake, O., Konstantinova, P., Ceylan, M., & Berkhout, B. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.07.007 · Cited by 293
Deglon, N., Tseng, J. L., Bensadoun, J.-C., Zurn, A. D., Arsenijevic, Y., Almeida, L. P. D., Zufferey, R., Trono, D., & Aebischer, P. (2000) · Human Gene Therapy · doi:10.1089/10430340050016256 · Cited by 292
Lentiviral-Mediated RNA Interference
Abbas-Terki, T., Blanco-Bose, W., Déglon, N., Pralong, W., & Aebischer, P. (2002) · Human Gene Therapy · doi:10.1089/104303402320987888 · Cited by 284
Efficient transgenesis in farm animals by lentiviral vectors
Hofmann, A., Kessler, B., Ewerling, S., Weppert, M., Vogg, B., Ludwig, H., Stojkovic, M., Boelhauve, M., Brem, G., Wolf, E., et al. (2003) · EMBO reports · doi:10.1038/sj.embor.7400007 · Cited by 280
Stable gene transfer to the nervous system using a non-primate lentiviral vector
Mitrophanous, K. A., Yoon, S., Rohll, J. B., Patil, D., Wilkes, F. J., Kim, V. N., Kingsman, S. M., Kingsman, A. J., & Mazarakis, N. D. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301023 · Cited by 278
Minimal Requirement for a Lentivirus Vector Based on Human Immunodeficiency Virus Type 1
Kim, V. N., Mitrophanous, K., Kingsman, S. M., & Kingsman, A. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.811-816.1998 · Cited by 269
Genotoxicity of Retroviral Integration In Hematopoietic Cells
Nienhuis, A. W., Dunbar, C. E., & Sorrentino, B. P. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.001 · Cited by 258
A Packaging Cell Line for Lentivirus Vectors
Kafri, T., van Praag, H., Ouyang, L., Gage, F. H., & Verma, I. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.576-584.1999 · Cited by 256
Self-citationRole of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import
Gallay, P., Stitt, V, Mundy, C., Oettinger, M., & Trono, D. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1027-1032.1996 · Cited by 252
Bartz, S. R., Rogel, M. E., & Emerman, M. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2324-2331.1996 · Cited by 251
Philippe, S., Sarkis, C., Barkats, M., Mammeri, H., Ladroue, C., Petit, C., Mallet, J., & Serguera, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606197103 · Cited by 249
Lentiviral Vectors: Regulated Gene Expression
Kafri, T., van Praag, H., Gage, F. H., & Verma, I. M. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0083 · Cited by 246
Self-citationShimotohno, K., & Temin, H. M. (1981) · Cell · doi:10.1016/0092-8674(81)90034-9 · Cited by 245
Themis, M., Waddington, S. N., Schmidt, M., von Kalle, C., Wang, Y., Al-Allaf, F., Gregory, L. G., Nivsarkar, M., Themis, M., Holder, M. V., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.07.358 · Cited by 243
Production of transgenic rats by lentiviral transduction of male germ-line stem cells
Hamra, F. K., Gatlin, J., Chapman, K. M., Grellhesl, D. M., Garcia, J. V., Hammer, R. E., & Garbers, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222561399 · Cited by 241
Wei, C. M., Gibson, M., Spear, P. G., & Scolnick, E. M. (1981) · Journal of Virology · doi:10.1128/jvi.39.3.935-944.1981 · Cited by 239
Human Immunodeficiency Virus cDNA Metabolism: Notable Stability of Two-Long Terminal Repeat Circles
Butler, S. L., Johnson, E. P., & Bushman, F. D. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.3739-3747.2002 · Cited by 238
Retroviral Virions and Genomes
Vogt, V. (1997) · Europe PMC (PubMed Central) · Cited by 236
Salmon, P., Kindler, V., Ducrey, O., Chapuis, B., Zubler, R. H., & Trono, D. (2000) · Blood · doi:10.1182/blood.v96.10.3392 · Cited by 233
Leavitt, A. D., Robles, G., Alesandro, N., & Varmus, H. E. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.721-728.1996 · Cited by 232
Kotsopoulou, E., Kim, V. N., Kingsman, A. J., Kingsman, S. M., & Mitrophanous, K. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4839-4852.2000 · Cited by 229
Sirven, A., Pflumio, F., Zennou, V., Titeux, M., Vainchenker, W., Coulombel, L., Dubart-Kupperschmitt, A., & Charneau, P. (2000) · Blood · doi:10.1182/blood.v96.13.4103 · Cited by 221
Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection
Morizono, K., Xie, Y., Ringpis, G.-E., Johnson, M., Nassanian, H., Lee, B., Wu, L., & Chen, I. S. Y. (2005) · Nature Medicine · doi:10.1038/nm1192 · Cited by 220
Rivella, S., May, C., Chadburn, A., Rivière, I., & Sadelain, M. (2003) · Blood · doi:10.1182/blood-2002-10-3305 · Cited by 220
VSV-G Pseudotyped Lentiviral Vector Particles Produced in Human Cells Are Inactivated by Human Serum
DePolo, N. J., Reed, J. D., Sheridan, P. L., Townsend, K., Sauter, S. L., Jolly, D. J., & Dubensky, T. W. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0116 · Cited by 220
A Stable System for the High-Titer Production of Multiply Attenuated Lentiviral Vectors
Klages, N., Zufferey, R., & Trono, D. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0103 · Cited by 219
Current Topics in Microbiology and Immunology
Lombardi, L. (1970) · Tumori Journal · doi:10.1177/030089167005600509 · Cited by 218
The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain
Zennou, V., Serguera, C., Sarkis, C., Colin, P., Perret, E., Mallet, J., & Charneau, P. (2001) · Nature Biotechnology · doi:10.1038/88115 · Cited by 214
Follenzi, A., Battaglia, M., Lombardo, A., Annoni, A., Roncarolo, M. G., & Naldini, L. (2004) · Blood · doi:10.1182/blood-2003-09-3217 · Cited by 212
Gene transfer vectors derived from equine infectious anemia virus
Olsen, J. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300768 · Cited by 212
Nègre, D., Mangeot, P.-E., Duisit, G., Blanchard, S., Vidalain, P.-O., Leissner, P., Winter, A.-J., Rabourdin-Combe, C., Mehtali, M., Moullier, P., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301292 · Cited by 206
Consiglio, A., Quattrini, A., Martino, S., Bensadoun, J. C., Dolcetta, D., Trojani, A., Benaglia, G., Marchesini, S., Cestari, V., Oliverio, A., et al. (2001) · Nature Medicine · doi:10.1038/85454 · Cited by 204
HIV-1 Infection Requires a Functional Integrase NLS
Bouyac-Bertoia, M., Dvorin, J. D., Fouchier, R. A. M., Jenkins, Y., Meyer, B. E., Wu, L. I., Emerman, M., & Malim, M. H. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00240-4 · Cited by 201
Lentiviral Gene Transfer to the Nonhuman Primate Brain
Kordower, J. H., Bloch, J., Ma, S. Y., Chu, Y., Palfi, S., Roitberg, B. Z., Emborg, M., Hantraye, P., Déglon, N., & Aebischer, P. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7178 · Cited by 199
Continuous high-titer HIV-1 vector production
Ikeda, Y., Takeuchi, Y., Martin, F., Cosset, F.-L., Mitrophanous, K., & Collins, M. (2003) · Nature Biotechnology · doi:10.1038/nbt815 · Cited by 198
Levasseur, D. N., Ryan, T. M., Pawlik, K. M., & Townes, T. M. (2003) · Blood · doi:10.1182/blood-2003-04-1251 · Cited by 195
Transient Gene Expression by Nonintegrating Lentiviral Vectors
Nightingale, S. J., Hollis, R. P., Pepper, K. A., Petersen, D., Yu, X.-J., Yang, C., Bahner, I., & Kohn, D. B. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.008 · Cited by 192
Sutton, R. E., Reitsma, M. J., Uchida, N., & Brown, P. O. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3649-3660.1999 · Cited by 192
Kinetic Analyses of Stability of Simple and Complex Retroviral Vectors
Higashikawa, F., & Chang, L.-J. (2001) · Virology · doi:10.1006/viro.2000.0743 · Cited by 188
Imren, S., Payen, E., Westerman, K. A., Pawliuk, R., Fabry, M. E., Eaves, C. J., Cavilla, B., Wadsworth, L. D., Beuzard, Y., Bouhassira, E. E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212507099 · Cited by 188
Self-Inactivating Lentiviral Vectors with U3 and U5 Modifications
Iwakuma, T., Cui, Y., & Chang, L.-J. (1999) · Virology · doi:10.1006/viro.1999.9850 · Cited by 187
Retroviral infection of non-dividing cells: Old and new perspectives
Yamashita, M., & Emerman, M. (2006) · Virology · doi:10.1016/j.virol.2005.09.012 · Cited by 187
Bensadoun, J.-C., Déglon, N., Tseng, J. L., Ridet, J.-L., Zurn, A. D., & Aebischer, P. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7409 · Cited by 184
Wong, L.-F., Goodhead, L., Prat, C., Mitrophanous, K. A., Kingsman, S. M., & Mazarakis, N. D. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.1 · Cited by 184
Successful correction of the human β-thalassemia major phenotype using a lentiviral vector
Puthenveetil, G., Scholes, J., Carbonell, D., Qureshi, N., Xia, P., Zeng, L., Li, S., Yu, Y., Hiti, A. L., Yee, J.-K., et al. (2004) · Blood · doi:10.1182/blood-2004-04-1427 · Cited by 182
Johnston, J. C., Gasmi, M., Lim, L. E., Elder, J. H., Yee, J.-K., Jolly, D. J., Campbell, K. P., Davidson, B. L., & Sauter, S. L. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.4991-5000.1999 · Cited by 181
Charneau, P., & Clavel, F. (1991) · Journal of Virology · doi:10.1128/jvi.65.5.2415-2421.1991 · Cited by 181
Pierson, T. C., Kieffer, T. L., Ruff, C. T., Buck, C., Gange, S. J., & Siliciano, R. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.4138-4144.2002 · Cited by 180
Production and concentration of pseudotyped HIV-1-based gene transfer vectors
Reiser, J. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301188 · Cited by 175
Guenechea, G., Gan, O. I., Inamitsu, T., Dorrell, C., Pereira, D. S., Kelly, M., Naldini, L., & Dick, J. E. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0077 · Cited by 174
Dvorin, J. D., Bell, P., Maul, G. G., Yamashita, M., Emerman, M., & Malim, M. H. (2002) · Journal of Virology · doi:10.1128/jvi.76.23.12087-12096.2002 · Cited by 172
Schambach, A., Bohne, J., Baum, C., Hermann, F. G., Egerer, L., von Laer, D., & Giroglou, T. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302698 · Cited by 170
Abordo-Adesida, E., Follenzi, A., Barcia, C., Sciascia, S., Castro, M. G., Naldini, L., & Lowenstein, P. R. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.741 · Cited by 170
Generation of Transgenic Cattle by Lentiviral Gene Transfer into Oocytes1
Hofmann, A., Zakhartchenko, V., Weppert, M., Sebald, H., Wenigerkind, H., Brem, G., Wolf, E., & Pfeifer, A. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.104.028472 · Cited by 170
A Phase I/II Clinical Trial of β‐Globin Gene Therapy for β‐Thalassemia
BANK, A., DORAZIO, R., & LEBOULCH, P. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.007 · Cited by 169
Generation of a Stable Cell Line Producing High-Titer Self-Inactivating Lentiviral Vectors
Xu, K., Ma, H., McCown, T. J., Verma, I. M., & Kafri, T. (2001) · Molecular Therapy · doi:10.1006/mthe.2000.0238 · Cited by 168
Self-citationComparison of lentiviral vector titration methods
Geraerts, M., Willems, S., Baekelandt, V., Debyser, Z., & Gijsbers, R. (2006) · BMC Biotechnology · doi:10.1186/1472-6750-6-34 · Cited by 167
Upscaling of lentiviral vector production by tangential flow filtration
Geraerts, M., Michiels, M., Baekelandt, V., Debyser, Z., & Gijsbers, R. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.778 · Cited by 167
Manilla, P., Rebello, T., Afable, C., Lü, X., Slepushkin, V., Humeau, L. M. P. F., Schonely, K., Ni, Y., Binder, G. K., Levine, B. L., et al. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.17 · Cited by 166
Sirven, A., Ravet, E., Charneau, P., Zennou, V., Coulombel, L., Guétard, D., Pflumio, F., & Dubart-Kupperschmitt, A. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0282 · Cited by 163
Ramezani, A., Hawley, T. S., & Hawley, R. G. (2003) · Blood · doi:10.1182/blood-2002-09-2991 · Cited by 162
Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer
Mostoslavsky, G., Fabian, A. J., Rooney, S., Alt, F. W., & Mulligan, R. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608130103 · Cited by 162
Targeting lentiviral vectors to specific cell types in vivo
Yang, L., Bailey, L., Baltimore, D., & Wang, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604993103 · Cited by 161
A New-Generation Stable Inducible Packaging Cell Line for Lentiviral Vectors
Farson, D. A., Witt, R. M., MCGUINNESS, R. P., Dull, T., Kelly, M., Song, J., Radeke, R., Bukovsky, A., Consiglio, A., & Naldini, L. (2001) · Human Gene Therapy · doi:10.1089/104303401750195935 · Cited by 160
Vigna, E., Cavalieri, S., Ailles, L., Geuna, M., Loew, R., Bujard, H., & Naldini, L. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0542 · Cited by 160
Efficient generation of transgenic pigs using equine infectious anaemia virus (EIAV) derived vector
Whitelaw, B., Radcliffe, P. A., Ritchie, W. A., Carlisle, A. J., Ellard, F. M., Pena, R. N., Rowe, J., Clark, A., King, T., & Mitrophanous, K. A. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.06.076 · Cited by 158
Baekelandt, V, Eggermont, K., Michiels, M., Nuttin, B., & Debyser, Z. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302094 · Cited by 153
Stitz, J., Buchholz, C. J., Engelstädter, M., Uckert, W., Bloemer, U., Schmitt, I., & Cichutek, K. (2000) · Virology · doi:10.1006/viro.2000.0394 · Cited by 152
Croyle, M. A., Callahan, S. M., Auricchio, A., Schumer, G., Linse, K. D., Wilson, J. M., Brunner, L. J., & Kobinger, G. (2003) · Journal of Virology · doi:10.1128/jvi.78.2.912-921.2004 · Cited by 152
Favre, D., Blouin, V., Provost, N., Spisek, R., Porrot, F., Bohl, D., Marmé, F., Chérel, Y., Salvetti, A., Hurtrel, B., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11605-11611.2002 · Cited by 150
Maele, B. V., Rijck, J. D., Clercq, E. D., & Debyser, Z. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4685-4694.2003 · Cited by 150
Gene therapy put on hold as third child develops cancer
Check, E. (2005) · Nature · doi:10.1038/433561a · Cited by 148
Generation of tissue-specific transgenic birds with lentiviral vectors
Scott, B. B., & Lois, C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508437102 · Cited by 148
Lizee, G. A., Aerts, J. L., Gonzales, M. I., Chinnasamy, N., Morgan, R. A., & Topalian, S. L. (2003) · Human Gene Therapy · doi:10.1089/104303403764539387 · Cited by 147
Teo, I. A., Veryard, C., Barnes, H. L., An, S., Jones, M., Lantos, P. L., Luthert, P. J., & Shaunak, S. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.2928-2933.1997 · Cited by 143
Novel Integrase-Defective Lentiviral Episomal Vectors for Gene Transfer
Vargas, J., Gusella, G. L., Najfeld, V., Klotman, M., & Cara, A. (2004) · Human Gene Therapy · doi:10.1089/104303404322959515 · Cited by 143
Bosch, A., Perret, E., Desmaris, N., Trono, D., & Heard, J. M. (2000) · Human Gene Therapy · doi:10.1089/10430340050015194 · Cited by 142
CRE recombinase-inducible RNA interference mediated by lentiviral vectors
Tiscórnia, G., Tergaonkar, V., Galimi, F., & Verma, I. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402107101 · Cited by 141
Development of a Novel Trans-Lentiviral Vector That Affords Predictable Safety
Wu, X., Wakefield, J. K., Liu, H., Xiao, H., Kralovics, R., Prchal, J. T., & Kappes, J. C. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0095 · Cited by 137 · cited 3×
“RCLs were eliminated through the development of a sophisticated HIV-1 trans-lentiviral vector packaging construct, in which the gag/pro/pol coding region is split into two expression cassettes: the gag/pro cassette and a vpr/pol fusion cassette [51, 52] (Fig.”
BackgroundMethodUse of RNA Polymerase II to Transcribe Artificial MicroRNAs
Zeng, Y., Cai, X., & Cullen, B. R. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)92022-8 · Cited by 134
Schroers, R., Sinha, I., Segall, H., Schmidt‐Wolf, I. G. H., Rooney, C. M., Brenner, M. K., Sutton, R. E., & Chen, S. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0027 · Cited by 134
Tschernutter, M., Schlichtenbrede, F. C., Howe, S. J., Balaggan, K. S., Munro, P., Bainbridge, J. W., Thrasher, A. J., Smith, A. J., & Ali, R. R. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302460 · Cited by 132
Interaction of Human Immunodeficiency Virus-Derived Vectors with Wild-Type Virus in Transduced Cells
Bukovsky, A. A., Song, J.-P., & Naldini, L. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.7087-7092.1999 · Cited by 132
Bemelmans, A., Kostic, C., Crippa, S. V., Hauswirth, W. W., Lem, J., Munier, F. L., Seeliger, M. W., Wenzel, A., & Arsenijévic, Y. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030347 · Cited by 131
Development of a Self-Inactivating, Minimal Lentivirus Vector Based on Simian Immunodeficiency Virus
Schnell, T., Foley, P., Wirth, M., Münch, J., & Überla, K. (2000) · Human Gene Therapy · doi:10.1089/10430340050015905 · Cited by 131
HIV-1 gene expression: lessons from provirus and non-integrated DNA
Wu, Y. (2004) · Retrovirology · doi:10.1186/1742-4690-1-13 · Cited by 131
Harnessing HIV for therapy, basic research and biotechnology
Wiznerowicz, M., & Trono, D. (2004) · Trends in biotechnology · doi:10.1016/j.tibtech.2004.11.001 · Cited by 124
Pluta, K. D., Luce, M. J., Bao, L., Agha‐Mohammadi, S., & Reiser, J. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.712 · Cited by 123
Saenz, D. T., Loewen, N. A., Peretz, M., Whitwam, T., Barraza, R., Howell, K. G., Holmes, J. M., Good, M. S., & Poeschla, E. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.2906-2920.2004 · Cited by 122
Development of Multigene and Regulated Lentivirus Vectors
Reiser, J., Lai, Z., Zhang, X., & Brady, R. O. (2000) · Journal of Virology · doi:10.1128/jvi.74.22.10589-10599.2000 · Cited by 121
Efficient Transduction of Nondividing Cells by Optimized Feline Immunodeficiency Virus Vectors
Curran, M. A., Kaiser, S. M., Achacoso, P. L., & Nolan, G. P. (2000) · Molecular Therapy · doi:10.1006/mthe.1999.0007 · Cited by 119
Christodoulopoulos, I., & Cannon, P. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4129-4138.2001 · Cited by 118
Pfeifer, A., Keßler, T., Yang, M., Baranov, E., Kootstra, N. A., Cheresh, D. A., Hoffman, R. M., & Verma, I. M. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0276 · Cited by 116
Latta-Mahieu, M., Rolland, M., Caillet, C., Wang, M., Kennel, P., Mahfouz, I., Loquet, I., Dedieu, J.-F., Mahfoudi, A., Trannoy, E., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340260201707 · Cited by 114
An, D. S., Wersto, R. P., Agricola, B. A., Metzger, M. E., Lu, S. Y., Amado, R. G., Chen, I. S. Y., & Donahue, R. E. (2000) · Journal of Virology · doi:10.1128/jvi.74.3.1286-1295.2000 · Cited by 114
Nakajima, N., Lu, R., & Engelman, A. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.7944-7955.2001 · Cited by 113
Lentiviral-mediated delivery of siRNAs for antiviral therapy
Morris, K. V., & Rossi, J. J. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302688 · Cited by 111
Gallichan, W. S., Kafri, T., Krahl, T., Verma, I. M., & Sarvetnick, N. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.18-2717 · Cited by 111
Self-citationKonvalinka, J., Litterst, M. A., Welker, R., Kottler, H., Rippmann, F., Heuser, A. M., & Kräusslich, H. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.7180-7186.1995 · Cited by 111
Koponen, J., Kankkonen, H. M., Kannasto, J., Wirth, T., Hillen, W., Bujard, H., & Ylä‐Herttuala, S. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301889 · Cited by 110
Agha‐Mohammadi, S., O'Malley, M., Etemad, A., Wang, Z., Xiao, X., & Lotze, M. T. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.566 · Cited by 110
Lentivirus Vector Gene Expression during ES Cell-Derived Hematopoietic Development In Vitro
Hamaguchi, I., Woods, N., Panagopoulos, I., Andersson, E., Mikkola, H. K. A., Fahlman, C., Zufferey, R., Carlsson, L., Trono, D., & Karlsson, S. (2000) · Journal of Virology · doi:10.1128/jvi.74.22.10778-10784.2000 · Cited by 109
Shen, H., Cheng, T., Preffer, F. I., Dombkowski, D., Tomasson, M. H., Golan, D. E., Yang, O. O., Hofmann, W., Sodroski, J., Luster, A. D., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.728-737.1999 · Cited by 108
Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors
Costello, E., Muñoz, M., Buetti, E., Meylan, P., Diggelmann, H., & Thali, M. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301135 · Cited by 98
Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins
Chinnasamy, D., Chinnasamy, N., Enriquez, M. J., Otsu, M., Morgan, R. A., & Candotti, F. (2000) · Blood · doi:10.1182/blood.v96.4.1309 · Cited by 97
Downstream processing of oncoretroviral and lentiviral gene therapy vectors
Segura, M. M., Kamen, A., & Garnier, A. (2006) · Biotechnology Advances · doi:10.1016/j.biotechadv.2005.12.001 · Cited by 97
Chang, A. H., & Sadelain, M. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300060 · Cited by 97
Bcl-xL protects adult septal cholinergic neurons from axotomized cell death
Blömer, U., Kafri, T., Randolph‐Moore, L., Verma, I. M., & Gage, F. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2603 · Cited by 94
Self-citationEfficient and sustained transgene expression in human corneal cells mediated by a lentiviral vector
Wang, X.-Y., Appukuttan, B., Ott, S. H., Patel, R. J., Irvine, J. A., Song, J., Park, J.-H. C., Smith, R. R., & Stout, J. T. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301075 · Cited by 94
Prospects and implications of using chromatin insulators in gene therapy and transgenesis
Targa, F. R., Valadéz-Graham, V., & Farrell, C. M. (2004) · BioEssays · doi:10.1002/bies.20059 · Cited by 90
Escarpe, P. A., Zayek, N., Chin, P. S., Borellini, F., Zufferey, R., Veres, G., & Kiermer, V. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00167-9 · Cited by 90
Tan, W., Dong, Z., Wilkinson, T. A., Barbas, C. F., & Chow, S. A. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1939-1948.2006 · Cited by 90
Limón, A., Nakajima, N., Lu, R., Ghory, H. Z., & Engelman, A. (2002) · Journal of Virology · doi:10.1128/jvi.76.23.12078-12086.2002 · Cited by 90
Logan, A. C., Haas, D. L., Kafri, T., & Kohn, D. B. (2004) · Journal of Virology · doi:10.1128/jvi.78.16.8421-8436.2004 · Cited by 89
Self-citationNi, Y., Sun, S. Y., Oparaocha, I., Humeau, L. M. P. F., Davis, B., Cohen, R., Binder, G. K., Chang, Y., Slepushkin, V., & Dropulić, B. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.726 · Cited by 88
Berkowitz, R. D., Ilves, H., Lin, W., Eckert, K., Coward, A., Tamaki, S. J., Veres, G., & Plavec, I. (2001) · Journal of Virology · doi:10.1128/jvi.75.7.3371-3382.2001 · Cited by 85
Kingsman, S. M., Mitrophanous, K., & Olsen, J. C. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302417 · Cited by 84
Quantitative Determination of Lentiviral Vector Particle Numbers by Real-Time PCR
Scherr, M., Battmer, K., Blömer, U., Ganser, A., & Grez, M. (2001) · BioTechniques · doi:10.2144/01313st05 · Cited by 84
Browning, M. T., Schmidt, R. D., Lew, K. A., & Rizvi, T. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.11.5129-5140.2001 · Cited by 82
Wolfgang, M. J., Eisele, S. G., Browne, M. A., Schotzko, M. L., Garthwaite, M. A., Durning, M., Ramezani, A., Hawley, R. G., Thomson, J. A., & Golos, T. G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181336098 · Cited by 82
Pacchia, A. L., Adelson, M. E., Kaul, M., Ron, Y., & Dougherty, J. P. (2001) · Virology · doi:10.1006/viro.2000.0787 · Cited by 81
Sandmeyer, S. B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031802100 · Cited by 79
Mortellaro, A., Hernández, R. J., Guerrini, M. M., Carlucci, F., Tabucchi, A., Ponzoni, M., Sanvito, F., Doglioni, C., Serio, C. D., Biasco, L., et al. (2006) · Blood · doi:10.1182/blood-2006-05-023507 · Cited by 77
Infection of intact human islets by a lentiviral vector
Giannoukakis, N., Mi, Z., Gambotto, A. A., Eramo, A., Ricordi, C., Trucco, M., & Robbins, P. D. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300996 · Cited by 74
Strang, B. L., Ikeda, Y., Cosset, F., Collins, M. K., & Takeuchi, Y. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302189 · Cited by 73
Mutational analysis of the vesicular stomatitis virus glycoprotein G for membrane fusion domains
Li, Y., Drone, C., Sat, E. W. Y., & Ghosh, H. P. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.4070-4077.1993 · Cited by 69
Brussel, A., Mathez, D., Broche, S., Lancar, R., Calvez, T., Sonigo, P., & Leibowitch, J. (2003) · AIDS · doi:10.1097/00002030-200303280-00001 · Cited by 69
Cited by
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
Komor, A. C., Badran, A. H., & Liu, D. R. (2017) · Cell · doi:10.1016/j.cell.2016.10.044 · Cited by 1,013
Viral and nonviral delivery systems for gene delivery
Nayerossadat, N., Maedeh, T., & Ali, P. (2012) · Advanced Biomedical Research · doi:10.4103/2277-9175.98152 · Cited by 858
Screening and large-scale expression of membrane proteins in mammalian cells for structural studies
Goehring, A., Lee, C.-H., Wang, K. H., Michel, J. C., Claxton, D. P., Baconguis, I., Althoff, T., Fischer, S., Garcia, K. C., & Gouaux, E. (2014) · Nature Protocols · doi:10.1038/nprot.2014.173 · Cited by 726
Lee, C. S., Bishop, E. S., Zhang, R., Yu, X., Farina, E. M., Yan, S., Zhao, C., Zeng, Z., Shu, Y., Wu, X., et al. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.04.001 · Cited by 691
Metadata
- Authors
- Cockrell, A. S., & Kafri, T.
- Venue
- Molecular Biotechnology
- Published
- 2007-04-17
- Volume
- 36
- Issue
- 3
- Pages
- 184-204
- ISSN
- 1073-6085 (ISSN-L)
- 1559-0305
- OpenAlex
- W2049340874
- Cited by
- 355
- References
- 240
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.